No.

Publication Date

Citing Article

1

2024

Yogita Dhas, Nupur Biswas, Divyalakshmi M.R., Lawrence D. Jones, Shashaanka Ashili. Repurposing metabolic regulators: antidiabetic drugs as anticancer agents, Molecular Biomedicine. 2024; 5: 40.  https://doi.org/10.1186/s43556-024-00204-z

2

2024

Monika Pliszka, Leszek Szablewski. Associations between Diabetes Mellitus and Selected Cancers, International Journal of Molecular Sciences. 2024; 25: 7476.  https://doi.org/10.3390/ijms25137476

3

2023

Lara Murphy, Diana Sherifali, Muhammad Usman Ali, Sarah Ibrahim. Influence of Diabetes Mellitus on Oncological Outcomes for Patients Living With Cancer, The Science of Diabetes Self-Management and Care. 2023; 49: 163.  https://doi.org/10.1177/26350106231153073

4

2024

Agostino Milluzzo, Lucia Manuella, Lucia Frittitta, Laura Sciacca. Cancer drugs and diabetic retinopathy: a dangerous, underestimated association, Metabolism and Target Organ Damage. 2024; 4:   https://doi.org/10.20517/mtod.2023.43

5

2023

Matheus Correia Casotti, Débora Dummer Meira, Lyvia Neves Rebello Alves, Barbara Gomes de Oliveira Bessa, Camilly Victória Campanharo, Creuza Rachel Vicente, Carla Carvalho Aguiar, Daniel de Almeida Duque, Débora Gonçalves Barbosa, Eldamária de Vargas Wolfgramm dos Santos, Fernanda Mariano Garcia, Flávia de Paula, Gabriel Mendonça Santana, Isabele Pagani Pavan, Luana Santos Louro, Raquel Furlani Rocon Braga, Raquel Silva dos Reis Trabach, Thomas Santos Louro, Elizeu Fagundes de Carvalho, Iúri Drumond Louro. Translational Bioinformatics Applied to the Study of Complex Diseases, Genes. 2023; 14: 419.  https://doi.org/10.3390/genes14020419

6

2022

Chandrakala Aluganti Narasimhulu, Dinender K. Singla. Doxorubicin-induced apoptosis enhances monocyte infiltration and adverse cardiac remodeling in diabetic animals, Canadian Journal of Physiology and Pharmacology. 2022; 100: 441.  https://doi.org/10.1139/cjpp-2021-0596

7

2024

Custodia García-Jiménez, José Manuel García-Martínez, Ana Chocarro-Calvo. 2024; 231.  https://doi.org/10.1016/B978-0-323-88426-6.00003-8

8

2024

Leanne Osgood, Nyangi Gityamwi, Debbie Cooke. Evaluating oncology healthcare professionals’ knowledge of diabetes mellitus, Cancer Nursing Practice. 2024;   https://doi.org/10.7748/cnp.2024.e1880

9

2024

Sixten Harborg, Kasper A Kjærgaard, Reimar Wernich Thomsen, Signe Borgquist, Deirdre Cronin-Fenton, Cathrine F Hjorth. New Horizons: Epidemiology of Obesity, Diabetes Mellitus, and Cancer Prognosis, The Journal of Clinical Endocrinology & Metabolism. 2024; 109: 924.  https://doi.org/10.1210/clinem/dgad450

10

2023

Siti Nor Ain Wahid Satar, Mohd Noor Norhayati, Lili Husniati Yaacob. Recurrent hypoglycemia in a patient with hepatocellular carcinoma, Electronic Journal of General Medicine. 2023; 20: em465.  https://doi.org/10.29333/ejgm/12903

11

2022

Agostino Milluzzo, Lucia Manuella, Emanuela Cannata, Giovanna Russo, Sandro La Vignera, Francesco Purrello, Andrea Di Cataldo, Laura Sciacca. Influence of Body Mass Index, Cancer Type and Treatment on Long-Term Metabolic and Liver Outcomes in Childhood Cancer Survivors, Journal of Clinical Medicine. 2022; 11: 878.  https://doi.org/10.3390/jcm11030878

12

2020

Erika Pedone, Andrea Laurenzi, Agnese Allora, Andrea Mario Bolla, Amelia Caretto. Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now?, Exploration of Medicine. 2020; 1: 314.  https://doi.org/10.37349/emed.2020.00021

13

2024

Agostino MILLUZZO, Martina BARCHITTA, Andrea MAUGERI, Antonella AGODI, Laura SCIACCA. Body Mass Index is related to short-term retinal worsening in type 2 diabetes mellitus patients treated with anticancer drugs, Minerva Endocrinology. 2024; 49:   https://doi.org/10.23736/S2724-6507.22.03653-3